Synthesis and Antitumor Activity of Heterocylic Aurone and Its Analogue Indanone Derivatives

IF 0.8 4区 化学 Q4 CHEMISTRY, ORGANIC Heterocycles Pub Date : 2023-01-01 DOI:10.3987/com-22-14764
H. Akber Aisa, C. Niu, Heng Wu, Ayitila Maimaitijiang, Dan-Jie Tang, Baoxing Xie
{"title":"Synthesis and Antitumor Activity of Heterocylic Aurone and Its Analogue Indanone Derivatives","authors":"H. Akber Aisa, C. Niu, Heng Wu, Ayitila Maimaitijiang, Dan-Jie Tang, Baoxing Xie","doi":"10.3987/com-22-14764","DOIUrl":null,"url":null,"abstract":"– Based on non-classical bioisosterism and the rule of alkene insertion, thirty-five heterocyclic aurones and its analogue indanones derivatives were designed and synthesized. They were evaluated for inhibitory activity against HELA, HT-29 and A549 and HepG2 human cancer cell lines. Among them, twenty-five compounds exhibited moderate to excellent antitumor activity. The minimum value of IC 50 was 1.649±0.083 μM (compound B1 ). The SAR showed that aurone with B ring as aromatic heterocycles such as 4-bromothiophene, quinoline, carbazole and indanone derivatives and some or indanone were more potent than others. Besides, the introduction of acetylated glycosides was beneficial to the activity. Compounds A1 , B1 , C5 , C8 , C10 , C11 , C12 and D1 were promising antitumor agents. Among them, compounds molecular docking studies were performed between B1 , C8 and potential targets Aurora B (PBD: 2BFY). On the basis, the chemical and physical properties, as well as ADMET of active compounds were predicted and analyzed. And it showed that most of compounds had good pharmacokinetic profiles and high safety profiles","PeriodicalId":13166,"journal":{"name":"Heterocycles","volume":"1 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heterocycles","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.3987/com-22-14764","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 1

Abstract

– Based on non-classical bioisosterism and the rule of alkene insertion, thirty-five heterocyclic aurones and its analogue indanones derivatives were designed and synthesized. They were evaluated for inhibitory activity against HELA, HT-29 and A549 and HepG2 human cancer cell lines. Among them, twenty-five compounds exhibited moderate to excellent antitumor activity. The minimum value of IC 50 was 1.649±0.083 μM (compound B1 ). The SAR showed that aurone with B ring as aromatic heterocycles such as 4-bromothiophene, quinoline, carbazole and indanone derivatives and some or indanone were more potent than others. Besides, the introduction of acetylated glycosides was beneficial to the activity. Compounds A1 , B1 , C5 , C8 , C10 , C11 , C12 and D1 were promising antitumor agents. Among them, compounds molecular docking studies were performed between B1 , C8 and potential targets Aurora B (PBD: 2BFY). On the basis, the chemical and physical properties, as well as ADMET of active compounds were predicted and analyzed. And it showed that most of compounds had good pharmacokinetic profiles and high safety profiles
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
杂环金酮及其类似物吲哚酮衍生物的合成及抗肿瘤活性研究
-基于非经典生物等构和烯烃插入规律,设计合成了35个杂环金酮及其类似物吲哚酮衍生物。测定了它们对HELA、HT-29、A549和HepG2人癌细胞的抑制活性。其中25个化合物具有中等至优异的抗肿瘤活性。IC 50最小值为1.649±0.083 μM(化合物B1)。SAR结果表明,4-溴噻吩、喹啉、咔唑和吲哚酮衍生物等含B环的芳香杂环的呋喃酮具有较强的药效。此外,乙酰化糖苷的引入有利于活性的提高。化合物A1、B1、C5、C8、C10、C11、C12和D1是有前景的抗肿瘤药物。其中,化合物B1、C8与潜在靶点Aurora B (PBD: 2BFY)进行了分子对接研究。在此基础上,对活性化合物的理化性质和ADMET进行了预测和分析。结果表明,大多数化合物具有良好的药动学特征和较高的安全性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Heterocycles
Heterocycles 化学-有机化学
CiteScore
1.50
自引率
0.00%
发文量
108
审稿时长
1 months
期刊介绍: Since its inception in 1973 HETEROCYCLES has provided a platform for the rapid exchange of research in the areas of organic, pharmaceutical, analytical, and medicinal chemistry of heterocyclic compounds in addition to communications, papers, reviews, a special section of the journal presents newly-discovered natural products whose structure has recently been established. Another section is devoted to the total synthesis of previously documented natural products with heterocyclic ring systems. Due to the fact that the journal is able to publish articles within two months of receipt of the manuscripts, researchers in this field can obtain up-to-date information on heterocyclic research by reading Heterocycles regularly. Audience: Organic and Physical Organic Chemists, Biochemists, Pharmacologists and Scientists studying heterocyclic compounds
期刊最新文献
Encapsulation of Cofacial Diarylacetylene Dimers Using [ Evaluation of 4,4'-Diaminodiphenylmethane as a Platform for Proton, Chemical Structures Diterpene Glycosides Derived from Synthesis and Properties of Novel Thiophene Polycyclic Aromatic Hydrocarbons Based on Pyrene and Their Radical Cations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1